Mesa Laboratories Inc (MLAB)
Return on total capital
| Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | — | -269,951 | 3,320 | 4,702 | -5,114 |
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | — | 145,393 | 393,480 | 393,801 | 406,227 |
| Return on total capital | — | -185.67% | 0.84% | 1.19% | -1.26% |
March 31, 2025 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $—K)
= —
Mesa Laboratories Inc's return on total capital has shown variability over the past few years. It was -1.26% as of March 31, 2021, indicating a slight negative return on the capital invested. The return improved to 1.19% by March 31, 2022, displaying a positive turnaround. However, the return decreased to 0.84% as of March 31, 2023, showing some decline in the company's capital efficiency.
The return on total capital took a significant negative turn to -185.67% as of March 31, 2024, which suggests that the company's capital investments resulted in substantial losses. The unavailability of data for March 31, 2025, indicates a lack of information for further assessment.
Overall, Mesa Laboratories Inc's return on total capital has been volatile, with periods of both positive and negative returns. Investors may need to closely monitor the company's capital allocation strategies and operational performance to assess its long-term sustainability and growth potential.
Peer comparison
Mar 31, 2025